Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35950293

A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer Med
Publication date
2023 Jan
First author
Attia S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Attia S
      type
      Author
    2. name
      Bolejack V
      type
      Author
    3. name
      Ganjoo KN
      type
      Author
    4. name
      George S
      type
      Author
    5. name
      Agulnik M
      type
      Author
    6. name
      Rushing D
      type
      Author
    7. name
      Loggers ET
      type
      Author
    8. name
      Livingston MB
      type
      Author
    9. name
      Wright J
      type
      Author
    10. name
      Chawla SP
      type
      Author
    11. name
      Okuno SH
      type
      Author
    12. name
      Reinke DK
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Attia S
      type
      Author
    2. name
      Bolejack V
      type
      Author
    3. name
      Ganjoo KN
      type
      Author
    4. name
      George S
      type
      Author
    5. name
      Agulnik M
      type
      Author
    6. name
      Rushing D
      type
      Author
    7. name
      Loggers ET
      type
      Author
    8. name
      Livingston MB
      type
      Author
    9. name
      Wright J
      type
      Author
    10. name
      Chawla SP
      type
      Author
    11. name
      Okuno SH
      type
      Author
    12. name
      Reinke DK
      type
      Author
    bibliography ids
    1. nci-bib-32709b42c7e7b076a30961a2
    book metadata
    content sha256
    58bb4aff89461b9ccf8475c07f8873af10e2344438b954e650d653304012d8fb
    document type
    citation
    dois
    1. 10.1002/cam4.5044
    electronic publication date
    display
    2022 Aug 10
    precision
    day
    year
    2022
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:35950293
    immutable id
    pubmed:35950293@58bb4aff89461b9ccf8475c07f8873af10e2344438b954e650d653304012d8fb
    journal
    abbreviation
    Cancer Med
    issn electronic
    2045-7634
    issn print
    Source null
    issue
    2
    name
    Cancer medicine
    nlm unique id
    101595310
    pages
    1532-1539
    volume
    12
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      35950293
      provenance
      batch id
      9d150d55960e0c12aada
      provider
      NCBI PubMed ESummary
      record sha256
      a4a8c724bcfef0b71241616aa015978fa0a2aff38d68a740b59788c88a0f153b
      response sha256
      2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
      retrieved at
      2026-09-09T23:48:09.820498+00:00
      publication date
      display
      2023 Jan
      precision
      month
      year
      2023
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/35950293/
      title
      A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.

      Preserved source evidence · Not medical advice